Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pulmonary Hypertension

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 97 articles:
HTML format
Text format



Single Articles


    December 2018
  1. GRUNIG E, Eichstaedt C, Barbera JA, Benjamin N, et al
    ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension.
    Eur Respir J. 2018 Dec 21. pii: 13993003.00332-2018.
    PubMed     Text format     Abstract available


  2. EYRIES M, Montani D, Nadaud S, Girerd B, et al
    Widening the landscape of heritable pulmonary hypertension mutations in pediatric and adult cases.
    Eur Respir J. 2018 Dec 21. pii: 13993003.01371-2018.
    PubMed     Text format     Abstract available


  3. GALIE N, McLaughlin VV, Rubin LJ, Simonneau G, et al
    An overview of the 6th World Symposium on Pulmonary Hypertension.
    Eur Respir J. 2018 Dec 14. pii: 13993003.02148-2018.
    PubMed     Text format    


  4. NATHAN SD, Barbera JA, Gaine SP, Harari S, et al
    Pulmonary hypertension in chronic lung disease and hypoxia.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01914-2018.
    PubMed     Text format     Abstract available


  5. HOEPER MM, Benza RL, Corris P, de Perrot M, et al
    Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01906-2018.
    PubMed     Text format     Abstract available


  6. MCGOON MD, Ferrari P, Armstrong I, Denis M, et al
    The importance of patient perspectives in pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01919-2018.
    PubMed     Text format     Abstract available


  7. VONK NOORDEGRAAF A, Chin KM, Haddad F, Hassoun PM, et al
    Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01900-2018.
    PubMed     Text format     Abstract available


  8. VACHIERY JL, Tedford RJ, Rosenkranz S, Palazzini M, et al
    Pulmonary hypertension due to left heart disease.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01897-2018.
    PubMed     Text format     Abstract available


  9. FROST A, Badesch D, Gibbs JSR, Gopalan D, et al
    Diagnosis of pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01904-2018.
    PubMed     Text format     Abstract available


  10. HUMBERT M, Guignabert C, Bonnet S, Dorfmuller P, et al
    Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01887-2018.
    PubMed     Text format     Abstract available


  11. KIM NH, Delcroix M, Jais X, Madani MM, et al
    Chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01915-2018.
    PubMed     Text format     Abstract available


  12. SIMONNEAU G, Montani D, Celermajer DS, Denton CP, et al
    Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01913-2018.
    PubMed     Text format     Abstract available


    November 2018
  13. KLOK FA, Barco S, Konstantinides SV, Dartevelle P, et al
    Determinants of diagnostic delay in Chronic Thromboembolic Pulmonary Hypertension: results from the European CTEPH registry.
    Eur Respir J. 2018 Nov 8. pii: 13993003.01687-2018.
    PubMed     Text format    


  14. SWIETLIK EM, Ruggiero A, Fletcher AJ, Taboada D, et al
    Limitations of resting haemodynamics in chronic thromboembolic disease without pulmonary hypertension.
    Eur Respir J. 2018 Nov 8. pii: 13993003.01787-2018.
    PubMed     Text format    


    October 2018
  15. DELCROIX M, Staehler G, Gall H, Grunig E, et al
    Risk assessment in medically treated Chronic Thromboembolic Pulmonary Hypertension patients.
    Eur Respir J. 2018 Oct 18. pii: 13993003.00248-2018.
    PubMed     Text format     Abstract available


  16. TURPIN M, Chantalat-Auger C, Parent F, Driss F, et al
    Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease.
    Eur Respir J. 2018;52.
    PubMed     Text format     Abstract available


    August 2018
  17. GRUNE J, Kuebler WM
    Is there a role for endothelin-1 receptor antagonists in the treatment of lung fibrosis associated with pulmonary hypertension?
    Eur Respir J. 2018;52.
    PubMed     Text format    


    July 2018
  18. SOUMAGNE T, Guillien A, Chambellan A, Hua-Huy T, et al
    Global Lung Initiative equations in pulmonary hypertension screening in systemic sclerosis.
    Eur Respir J. 2018 Jul 26. pii: 13993003.00528-2018.
    PubMed     Text format    


  19. QUADERY SR, Swift AJ, Billings C, Thompson A, et al
    The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2018 Jul 12. pii: 13993003.00589-2018.
    PubMed     Text format     Abstract available


  20. BELLAYE PS, Yanagihara T, Granton E, Sato S, et al
    Macitentan reduces progression of TGF-beta1-induced pulmonary fibrosis and pulmonary hypertension.
    Eur Respir J. 2018 Jul 5. pii: 13993003.01857-2017.
    PubMed     Text format    


    May 2018
  21. KING CS, Brown AW, Shlobin OA, Weir N, et al
    Prevalence and Impact of WHO Group 3 Pulmonary Hypertension in Advanced Idiopathic Nonspecific Interstitial Pneumonia.
    Eur Respir J. 2018 May 17. pii: 13993003.00545-2018.
    PubMed     Text format    


  22. GUAZZI M
    Partitioning of pulmonary vascular resistances in group 2 pulmonary hypertension: insightful suggestions for bridging haemodynamics to underlying mechanisms.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    April 2018
  23. HOEPER MM
    Chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: to screen or not to screen?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  24. CONDLIFFE R, Kovacs G
    Identifying early pulmonary arterial hypertension in patients with systemic sclerosis.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    March 2018
  25. GERGES C, Gerges M, Fesler P, Maria Pistritto A, et al
    In-depth hemodynamic phenotyping of pulmonary hypertension due to left heart disease.
    Eur Respir J. 2018 Mar 29. pii: 13993003.00067-2018.
    PubMed     Text format     Abstract available


  26. COGHLAN G, Wolf M, Distler O, Denton CP, et al
    Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis.
    Eur Respir J. 2018 Mar 21. pii: 13993003.01197-2017.
    PubMed     Text format     Abstract available


  27. BONNET S, Boucherat O
    The ROS controversy in hypoxic pulmonary hypertension revisited.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  28. OLSCHEWSKI H, Kovacs G, Herve P
    Pulmonary capillary recruitment in exercise and pulmonary hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  29. LANGLEBEN D, Orfanos SE
    Pulmonary capillary recruitment in exercise and pulmonary hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  30. BOUCLY A, Weatherald J, Humbert M, Sitbon O, et al
    Risk assessment in pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  31. HOEPER MM, Pittrow D, Opitz C, Gibbs JSR, et al
    Risk assessment in pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  32. DACCORD C, Letovanec I, Yerly P, Bloch J, et al
    First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    February 2018
  33. CARAVITA S, Dewachter C, Soranna D, Carolino D'Araujo S, et al
    Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis.
    Eur Respir J. 2018 Feb 8. pii: 13993003.02427-2017.
    PubMed     Text format    


  34. PAK O, Scheibe S, Esfandiary A, Gierhardt M, et al
    Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension.
    Eur Respir J. 2018 Feb 1. pii: 13993003.01024-2017.
    PubMed     Text format     Abstract available


  35. HSU S, Tedford RJ
    Will we be singing a different tune on combined post- and pre-capillary pulmonary hypertension?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  36. VACHIERY JL, Delcroix M, Al-Hiti H, Efficace M, et al
    Macitentan in pulmonary hypertension due to left ventricular dysfunction.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


    January 2018
  37. TRAMPER J, Nossent EJ, Lely RJ, Krouwels FH, et al
    Balloon pulmonary angioplasty in sarcoid-related pulmonary hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  38. COTTIN V, Price LC, Valenzuela C
    The unmet medical need of pulmonary hypertension in idiopathic pulmonary fibrosis.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  39. KUMAR R, Graham B
    How does inflammation contribute to pulmonary hypertension?
    Eur Respir J. 2018;51.
    PubMed     Text format    


    October 2017
  40. BAUGHMAN RP, Shlobin OA
    Treatment of sarcoidosis-associated pulmonary hypertension: so close, and yet so far.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  41. DEGANO B, Soumagne T, Delaye T, Berger P, et al
    Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  42. BOUCLY A, Cottin V, Nunes H, Jais X, et al
    Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    September 2017
  43. WEATHERALD J, Boucly A, Lau E, Godinas L, et al
    Are indexed values better for defining exercise pulmonary hypertension?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  44. MULLIN CJ, Hsu S, Amancherla K, Wand A, et al
    Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    August 2017
  45. HOEPER MM, Kramer T, Pan Z, Eichstaedt CA, et al
    Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    July 2017
  46. BOGAARD HJ
    Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that?
    Eur Respir J. 2017;50.
    PubMed     Text format    


    June 2017
  47. OLSSON KM, Wiedenroth CB, Kamp JC, Breithecker A, et al
    Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    May 2017
  48. JOUNEAU S, Ballerie A, Kerjouan M, Demant X, et al
    Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  49. SANGES S, Prevotat A, Fertin M, Terriou L, et al
    Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  50. KLOK FA, Hoeper MM
    Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat.
    Eur Respir J. 2017;49.
    PubMed     Text format    


    March 2017
  51. NEDER JA, Berton DC, Arbex FF, Alencar MC, et al
    Physiological and clinical relevance of exercise ventilatory efficiency in COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    February 2017
  52. SCHERRER U, Verges S
    Sleep apnoea and pulmonary hypertension in high-altitude dwellers: more than an association?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  53. SIMONNEAU G, Hoeper MM
    Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  54. ENDE-VERHAAR YM, Cannegieter SC, Vonk Noordegraaf A, Delcroix M, et al
    Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  55. NAKHLEH MK, Haick H, Humbert M, Cohen-Kaminsky S, et al
    Volatolomics of breath as an emerging frontier in pulmonary arterial hypertension.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    December 2016
  56. LATSHANG TD, Furian M, Aeschbacher SS, Ulrich S, et al
    Association between sleep apnoea and pulmonary hypertension in Kyrgyz highlanders.
    Eur Respir J. 2016 Dec 22. pii: 1601530. doi: 10.1183/13993003.01530-2016.
    PubMed     Text format     Abstract available


    November 2016
  57. RIOU M, Seferian A, Savale L, Chaumais MC, et al
    Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity.
    Eur Respir J. 2016;48:1517-1519.
    PubMed     Text format    


    October 2016
  58. EID-LIDT G, Gaspar J, Sandoval J, Gonzalez-Pacheco H, et al
    Persistent pulmonary hypertension and right ventricular function after percutaneous mechanical thrombectomy in severe acute pulmonary embolism.
    Eur Respir J. 2016 Oct 20. pii: ERJ-00910-2016. doi: 10.1183/13993003.00910-2016
    PubMed     Text format    


    September 2016

  59. "New potential diagnostic biomarkers for pulmonary hypertension." Svenja L. Tiede, Henning Gall, Oliver Dorr, Marina dos Santos Guilherme, Christian Troidl, Christoph Liebetrau, Sandra Voss, Robert Voswinckel, Ralph T. Schermuly, Werner Seeger, Friedr
    Eur Respir J. 2016;48:962.
    PubMed     Text format    


  60. LEVY M, Eyries M, Szezepanski I, Ladouceur M, et al
    Genetic analyses in a cohort of children with pulmonary hypertension.
    Eur Respir J. 2016 Sep 1. pii: ERJ-00211-2016. doi: 10.1183/13993003.00211-2016.
    PubMed     Text format     Abstract available


    August 2016
  61. NAGARAJ C, Tang B, Nagy BM, Papp R, et al
    Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension.
    Eur Respir J. 2016 Aug 18. pii: ERJ-01814-2015. doi: 10.1183/13993003.01814-2015
    PubMed     Text format     Abstract available


  62. GAMEN E, Seeger W, Pullamsetti SS
    The emerging role of epigenetics in pulmonary hypertension.
    Eur Respir J. 2016 Aug 4. pii: ERJ-01714-2015. doi: 10.1183/13993003.01714-2015.
    PubMed     Text format     Abstract available



  63. ERJ August Podcast: management of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016;48:E68.
    PubMed     Text format    


    July 2016
  64. PARPALEIX A, Amsellem V, Houssaini A, Abid S, et al
    Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension.
    Eur Respir J. 2016 Jul 13. pii: ERJ-01448-2015. doi: 10.1183/13993003.01448-2015
    PubMed     Text format     Abstract available


    June 2016
  65. HASSOUN PM, Nathan SD
    Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science.
    Eur Respir J. 2016;47:1615-7.
    PubMed     Text format    


    May 2016
  66. GERGES M, Gerges C, Lang IM
    How to define pulmonary hypertension due to left heart disease.
    Eur Respir J. 2016 May 12. pii: ERJ-00432-2016. doi: 10.1183/13993003.00432-2016
    PubMed     Text format    


    April 2016
  67. HOFFMANN J, Wilhelm J, Olschewski A, Kwapiszewska G, et al
    Microarray analysis in pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-02030-2015. doi: 10.1183/13993003.02030-2015
    PubMed     Text format     Abstract available


  68. NEDER JA, Ramos RP, Ota-Arakaki JS, Ferreira EM, et al
    Insights into ventilation-gas exchange coupling in chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-01948-2015. doi: 10.1183/13993003.01948-2015
    PubMed     Text format    


  69. MATHAI SC, Ghofrani HA, Mayer E, Pepke-Zaba J, et al
    Quality of life in patients with chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-01626-2015. doi: 10.1183/13993003.01626-2015
    PubMed     Text format     Abstract available


  70. OLIVEIRA RK, Agarwal M, Tracy JA, Karin AL, et al
    Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics.
    Eur Respir J. 2016;47:1179-88.
    PubMed     Text format     Abstract available


    March 2016
  71. GODINAS L, Lau EM, Chemla D, Lador F, et al
    Diagnostic concordance of different criteria for exercise pulmonary hypertension in subjects with normal resting pulmonary artery pressure.
    Eur Respir J. 2016 Mar 30. pii: ERJ-01678-2015. doi: 10.1183/13993003.01678-2015
    PubMed     Text format    


  72. MILARA J, Escriva J, Ortiz JL, Juan G, et al
    Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: an ex vivo/in vitro study.
    Eur Respir J. 2016 Mar 23. pii: ERJ-01259-2015. doi: 10.1183/13993003.01259-2015
    PubMed     Text format     Abstract available


    February 2016
  73. LAHM T
    Sex differences in pulmonary hypertension: are we cleaning up the mess?
    Eur Respir J. 2016;47:390-3.
    PubMed     Text format    


  74. TOSHNER M
    Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances?
    Eur Respir J. 2016;47:388-9.
    PubMed     Text format    


  75. MALENFANT S, Perros F
    beta-blockers in pulmonary arterial hypertension: generation might matter.
    Eur Respir J. 2016;47:682-4.
    PubMed     Text format    


  76. PRICE LC, Wort SJ
    Earlier diagnosis and international registries may improve outcomes in pulmonary tumour thrombotic microangiopathy.
    Eur Respir J. 2016;47:690-1.
    PubMed     Text format    


  77. MERAD M, Savale L, Antoun S, Vincent F, et al
    Is there hope of improving the prognosis of pulmonary tumour thrombotic microangiopathy?
    Eur Respir J. 2016;47:688-90.
    PubMed     Text format    


  78. PUENTE-MAESTU L, Palange P, Casaburi R, Laveneziana P, et al
    Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement.
    Eur Respir J. 2016;47:429-60.
    PubMed     Text format     Abstract available


  79. RODRIGUEZ-ROISIN R, Bartolome SD, Huchon G, Krowka MJ, et al
    Inflammatory bowel diseases, chronic liver diseases and the lung.
    Eur Respir J. 2016;47:638-50.
    PubMed     Text format     Abstract available


    January 2016
  80. KOVACS G, Avian A, Olschewski H
    Proposed new definition of exercise pulmonary hypertension decreases false positive cases.
    Eur Respir J. 2016 Jan 7. pii: ERJ-01394-2015. doi: 10.1183/13993003.01394-2015.
    PubMed     Text format    


  81. QUILOT FM, Georges M, Favrolt N, Beltramo G, et al
    Pulmonary hypertension associated with ponatinib therapy.
    Eur Respir J. 2016 Jan 7. pii: ERJ-01110-2015. doi: 10.1183/13993003.01110-2015.
    PubMed     Text format    


  82. SOMMER N, Strielkov I, Pak O, Weissmann N, et al
    Oxygen sensing and signal transduction in hypoxic pulmonary vasoconstriction.
    Eur Respir J. 2016;47:288-303.
    PubMed     Text format     Abstract available


    December 2015
  83. SABOOR F, Reckmann AN, Tomczyk CU, Peters DM, et al
    Nestin-expressing vascular wall cells drive development of pulmonary hypertension.
    Eur Respir J. 2015 Dec 23. pii: ERJ-00574-2015. doi: 10.1183/13993003.00574-2015
    PubMed     Text format     Abstract available


  84. GIRERD B, Montani D, Jais X, Eyries M, et al
    Genetic counselling in a national referral centre for pulmonary hypertension.
    Eur Respir J. 2015 Dec 23. pii: ERJ-00717-2015. doi: 10.1183/13993003.00717-2015
    PubMed     Text format     Abstract available



  85. "2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)."
    Eur Respir J. 2015;46:1855-6.
    PubMed     Text format    


  86. SAVALE L, Chaumais MC, Sitbon O, Humbert M, et al
    Pulmonary arterial hypertension in patients treated with interferon.
    Eur Respir J. 2015;46:1851-3.
    PubMed     Text format    


  87. PRELLA M, Yerly P, Nicod LP, Aubert JD, et al
    Pulmonary arterial hypertension in patients treated with interferon.
    Eur Respir J. 2015;46:1849-51.
    PubMed     Text format    


    November 2015
  88. BARBERA JA, Blanco I
    Gaining insights into pulmonary hypertension in respiratory diseases.
    Eur Respir J. 2015;46:1247-50.
    PubMed     Text format    


    October 2015
  89. HUITEMA MP, Spee M, Vorselaars VM, Boerman S, et al
    Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis.
    Eur Respir J. 2015 Oct 22. pii: ERJ-01319-2015. doi: 10.1183/13993003.01319-2015
    PubMed     Text format    



  90. ERJ October Podcast: new guidelines for diagnosis and treatment of pulmonary hypertension.
    Eur Respir J. 2015;46:E58.
    PubMed     Text format    


  91. LAU EM, Tamura Y, McGoon MD, Sitbon O, et al
    The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress.
    Eur Respir J. 2015;46:879-82.
    PubMed     Text format    


    June 2015
  92. MANDERS E, Ruiter G, Bogaard HJ, Stienen GJ, et al
    Quadriceps muscle fibre dysfunction in patients with pulmonary arterial hypertension.
    Eur Respir J. 2015;45:1737-40.
    PubMed     Text format    


  93. ROBERTSON HT
    Dead space: the physiology of wasted ventilation.
    Eur Respir J. 2015;45:1704-16.
    PubMed     Text format     Abstract available


    April 2015
  94. HUERTAS A, Tu L, Thuillet R, Le Hiress M, et al
    Leptin signalling system as a target for pulmonary arterial hypertension therapy.
    Eur Respir J. 2015;45:1066-80.
    PubMed     Text format     Abstract available


    March 2015
  95. HOUSTON BA, Tedford RJ
    Stressing the stepchild: assessing right ventricular contractile reserve in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:604-7.
    PubMed     Text format    


  96. SHARMA T, Lau EM, Choudhary P, Torzillo PJ, et al
    Dobutamine stress for evaluation of right ventricular reserve in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:700-8.
    PubMed     Text format     Abstract available


    January 2015
  97. COURAND PY, Pina Jomir G, Khouatra C, Scheiber C, et al
    Prognostic value of right ventricular ejection fraction in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:139-49.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: